España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Duncan Williams
UPDATE: Duncan Williams Downgrades Healthcare Services Group to Hold, Removes PT
Duncan Williams Downgrades Healthcare Services Group to Hold, Removes PT
Duncan Williams Reiterates ENSCO Strong Buy, PT
Duncan Williams Downgrades Healthcare Services Group to Hold, Removes PT
Duncan Williams Reiterates ENSCO Strong Buy, PT
Duncan Williams Maintains Forest Laboratories Buy, $48 PT
Duncan Williams Raises Kensey Nash PT, Maintains Buy
Duncan Williams Maintains Forest Laboratories Buy, $48 PT
Duncan Williams Raises Kensey Nash PT, Maintains Buy
Duncan Williams Maintains Pernix Therapeutics Buy, PT
Duncan Williams Upgrades Healthcare Services To Buy, $16.75 PT
Read More...
Duncan Williams Recent News
Duncan Williams Reiterates Hold on Tidewater
Duncan Williams Lowers PT on eResearch Technology to $8
Duncan Williams Reiterates Strong Buy on Ensco, Raises PT to $88.50
Duncan Williams Reiterates Reduce on Helmerich & Payne
Duncan Williams Reiterates Hold on Computer Programs and Systems
Duncan Williams Reiterates Buy and PT of $80 on Varian Medical
Duncan Williams Initiates Coverage of Tornier with Hold
Duncan Williams Initiates Tornier At Hold
Duncan Williams Maintains Buy on Forest Laboratories
Duncan Williams Reiterates Strong Buy and PT of $61.50 on Noble
Duncan Williams Reiterates Strong Buy and PT of $101.25 on Transocean
Duncan Williams Maintains Cadence Pharmaceuticals Strong Buy, $14 PT
Duncan Williams Reiterates Noble Strong Buy, $61.50 PT
Duncan Williams Reiterates Atwood Oceanics Strong Buy, $60.75 PT
Duncan Williams Maintains Medicis Pharmaceutical Buy, $43 PT
Duncan Williams Reiterates Strong Buy and PT of $16 on Willbros
Duncan Williams Upgrades Rowan Companies To Strong Buy, PT At $50.25
Duncan Williams Raises PT On Forest Laboratories To $45
Duncan Williams Maintains Nabors Industries Buy, $37.50 PT
Duncan Williams Maintains Obagi Medical Products Hold
Duncan Williams Raises PT On Noble Corporation To $61.50
Duncan-Williams Upgrades Diamond Offshore Drilling to Buy, Raises PT to $86.25 (DO)
Duncan Williams Upgrades Atwood Oceanics To Strong Buy, PT To $60.75